Crucial role of TNF-α in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3645-3651

  Prévost Blondel, Armelle ^a   Roth, Evelyn ^a   Rosenthal, Felicia M ^b   Pircher, Hanspeter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Cellgenix GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOLOGY; CELLULAR IMMUNITY; LUNG CARCINOMA; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0343183120     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3645     Document Type: Article

References (39)

1. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
2. Kundig, T. M., M. F. Bachmann, L. Lefrancois, L. Puddington, H. Hengartner, and R. M. Zinkernagel. 1993. Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells. J. Immunol. 150:4450.
3. Grabbe, S., D. Beissert, T. Shwaertz, and R. D. Granstein. 1995. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today 16:117.
4. Wang, R., and M. Taniguchi. 1995. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody. J. Immunol. 154:1797.
5. Chen, P. W., M. Wang, V. Bronte, Y. Zhai, S. A. Rosenberg, and N. P. Restifo. 1996. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156:224.
6. Ciernik, F. I., J. A. Berzofsky, and D. P. Carbone. 1996. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccine expressing single T cell epitopes. J. Immunol. 156:2369.
7. Iwasaki, A., and B. H. Barber. 1998. Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope expressing tumor. Cancer Immunol. Immunother. 45:273.
8. Fayolle, C., D. Ladant, A. Karimova, and C. Leclerc. 1999. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope. J. Immunol. 162:4157.
9. Tobery, T., and R. F. Siliciano. 1999. Induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen. J. Immunol. 162:639.
10. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Elsenstein, and L. Elsenbach. 1994. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67.
11. Mandelboim, O., E. Vadai, M. Fridkin, A. Katz-Hillel, M. Feldman, G. Berke, and L. Eisenbach. 1995. Regression of established murine carcinoma metastases following vaccination with tumor-associated antigen peptides. Nat. Med. 1:1179.
12. + T cells. Science 248:1227.
13. Gosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
14. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
15. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739.
16. Korner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600.
17. Pircher, H., K. Burki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342:559.
18. Kyburz, D., P. Aichele, D. E. Speiser, H. Hengartner, R. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956.
19. + T cells to cause immunopathology. J. Exp. Med. 187:763.
20. Eisenbach, L., S. Segal, and M. Feldman. 1983. MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int. J. Cancer 32:113.
21. Prévost-Blondel, A., C. Zimmermann, C. Stemmer, P. Kulmburg, F. M. Rosenthal, and H. Pircher. 1998. Tumor infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo. J. Immunol. 161:2187.
22. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods 33:191.
23. Ohashi, P. S., R. M. Zinkernagel, I. Leuscher, H. Hengartner, and H. Pircher. 1993. Enhanced positive selection of a transgenic TCR by a restriction element that does not permit negative selection. Int. Immunol. 5:131.
24. b molecules. Virology 234:62.
25. + T cell specificity and compensates for loss of T cell receptor contacts with the specific peptide. J. Exp. Med. 189:883.
26. Hermans, I. F., A. Daish, J. Yang, D. S. Ritchie, and F. Ronchese. 1998. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors. Cancer Res. 58:3909.
27. Kundig, T. M., M. F. Bachmann, C. DiPaolo, J. J. L. Simard, M. Battegay, H. Lother, A. Gessner, K. Kuhlcke, P. S. Ohashi, H. Hengartner, and R. M. Zinkernagel. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268: 1343.
28. + CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL. J. Immunol. 163:184.
29. Maass, G., W. Schmidt, M. Berger, F. Schilcher, F. Koszik, A. Schneeberger, G. Stingl, M. L. Birnstiel, and T. Schweighoffer. 1995. Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination. Proc. Natl. Acad. Sci. USA 92:5540.
30. Maric, M., P. Zheng, S. Sarma, Y. Guo, and Y. Liu. 1998. Maturation of cytotoxic T lymphocytes against a B7-transfected non metastatic tumor: a critical role for costimulation by B7 on both tumor and host antigen-presenting cells. Cancer Res. 58:3376.
31. van den Broek, M. F., D. Kagi, R. M. Zinkernagel, and H. Hengartner. 1995. Perform dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514.
32. Rosendahl, A., K. Kristensson, J. Hansson, K. Riesbeck, T. Kalland, and M. Dohlsten. 1998. Perform and IFN-γ are involved in the antitumor effects of antibody-targeted superantigens. J. Immunol. 160:5309.
33. Sayers, T. J., A. D. Brooks, J.-K. Lee, R. G. Fenton, K. L. Komschlies, J. M. Wigginton, R. Winkler-Pickett, and R. H. Wiltrout. 1998. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus fas-mediated pathways in lysis by NK and T cells. J. Immunol. 161:3957.
34. Smyth, M. J., J. M. Kelly, A. G. Baxter, H. Komer, and J. D. Sedgwick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med 9:1611.
35. Smyth, M. J., K. Y. T. Thia, E. Cretney, J. M. Kelly, M. B. Snook, C. A. Forbes, and A.A. Scalzo. 1999. Perform is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162:6658.
36. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Shreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95:7556.
37. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P. G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340.
38. Fogler, W. E., K. Volker, K. L. McCormick, M. Watanabe, J. R. Ortaldo, and R. H. Wiltrout. 1996. NK cell infiltration into lung, liver and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707.
39. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397.